These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 27585283)

  • 41. Whole-exome sequencing identifies multiple loss-of-function mutations of NF-κB pathway regulators in nasopharyngeal carcinoma.
    Zheng H; Dai W; Cheung AK; Ko JM; Kan R; Wong BW; Leong MM; Deng M; Kwok TC; Chan JY; Kwong DL; Lee AW; Ng WT; Ngan RK; Yau CC; Tung S; Lee VH; Lam KO; Kwan CK; Li WS; Yau S; Chan KW; Lung ML
    Proc Natl Acad Sci U S A; 2016 Oct; 113(40):11283-11288. PubMed ID: 27647909
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Activating the innate immune response to counter chronic hepatitis B virus infection.
    Lamb C; Arbuthnot P
    Expert Opin Biol Ther; 2016 Dec; 16(12):1517-1527. PubMed ID: 27603796
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Heat shock proteins stimulate APOBEC-3-mediated cytidine deamination in the hepatitis B virus.
    Chen Z; Eggerman TL; Bocharov AV; Baranova IN; Vishnyakova TG; Kurlander R; Patterson AP
    J Biol Chem; 2017 Aug; 292(32):13459-13479. PubMed ID: 28637869
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Understanding the regulation of APOBEC3 expression: Current evidence and much to learn.
    Covino DA; Gauzzi MC; Fantuzzi L
    J Leukoc Biol; 2018 Mar; 103(3):433-444. PubMed ID: 29345375
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Enzyme cycling contributes to efficient induction of genome mutagenesis by the cytidine deaminase APOBEC3B.
    Adolph MB; Love RP; Feng Y; Chelico L
    Nucleic Acids Res; 2017 Nov; 45(20):11925-11940. PubMed ID: 28981865
    [TBL] [Abstract][Full Text] [Related]  

  • 46. APOBEC: From mutator to editor.
    Yang B; Li X; Lei L; Chen J
    J Genet Genomics; 2017 Sep; 44(9):423-437. PubMed ID: 28964683
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MicroRNAs regulate APOBEC gene expression.
    Cao W; Wu W
    Histol Histopathol; 2018 Feb; 33(2):117-120. PubMed ID: 28604942
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Activation induced cytidine deaminase mutant (AID-His130Pro) from Hyper IgM 2 patient retained mutagenic activity on SHM artificial substrate.
    Ouadani H; Ben-Mustapha I; Ben-Ali M; Larguèche B; Jovanic T; Garcia S; Arcangioli B; Elloumi-Zghal H; Fathallah D; Hachicha M; Masmoudi H; Rougeon F; Barbouche MR
    Mol Immunol; 2016 Nov; 79():77-82. PubMed ID: 27716525
    [TBL] [Abstract][Full Text] [Related]  

  • 49. BRCT-domain protein BRIT1 influences class switch recombination.
    Yen WF; Chaudhry A; Vaidyanathan B; Yewdell WT; Pucella JN; Sharma R; Liang Y; Li K; Rudensky AY; Chaudhuri J
    Proc Natl Acad Sci U S A; 2017 Aug; 114(31):8354-8359. PubMed ID: 28724724
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A transcriptional serenAID: the role of noncoding RNAs in class switch recombination.
    Yewdell WT; Chaudhuri J
    Int Immunol; 2017 Apr; 29(4):183-196. PubMed ID: 28535205
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Family-Wide Comparative Analysis of Cytidine and Methylcytidine Deamination by Eleven Human APOBEC Proteins.
    Ito F; Fu Y; Kao SA; Yang H; Chen XS
    J Mol Biol; 2017 Jun; 429(12):1787-1799. PubMed ID: 28479091
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Biochemical Regulatory Features of Activation-Induced Cytidine Deaminase Remain Conserved from Lampreys to Humans.
    Quinlan EM; King JJ; Amemiya CT; Hsu E; Larijani M
    Mol Cell Biol; 2017 Oct; 37(20):. PubMed ID: 28716949
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CD25
    Kaku H; Holodick NE; Tumang JR; Rothstein TL
    Front Immunol; 2017; 8():672. PubMed ID: 28676801
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A Novel Regulator of Activation-Induced Cytidine Deaminase/APOBECs in Immunity and Cancer: Schrödinger's CATalytic Pocket.
    King JJ; Larijani M
    Front Immunol; 2017; 8():351. PubMed ID: 28439266
    [TBL] [Abstract][Full Text] [Related]  

  • 55. APOBEC3 deletion increases the risk of breast cancer: a meta-analysis.
    Han Y; Qi Q; He Q; Sun M; Wang S; Zhou G; Sun Y
    Oncotarget; 2016 Nov; 7(46):74979-74986. PubMed ID: 27602762
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular Mechanisms of Somatic Hypermutation and Class Switch Recombination.
    Methot SP; Di Noia JM
    Adv Immunol; 2017; 133():37-87. PubMed ID: 28215280
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A double-strand break can trigger immunoglobulin gene conversion.
    Bastianello G; Arakawa H
    Nucleic Acids Res; 2017 Jan; 45(1):231-243. PubMed ID: 27701075
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Progressive APOBEC3B mRNA expression in distant breast cancer metastases.
    Sieuwerts AM; Schrijver WA; Dalm SU; de Weerd V; Moelans CB; Ter Hoeve N; van Diest PJ; Martens JW; van Deurzen CH
    PLoS One; 2017; 12(1):e0171343. PubMed ID: 28141868
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Heat Increases the Editing Efficiency of Human Papillomavirus E2 Gene by Inducing Upregulation of APOBEC3A and 3G.
    Yang Y; Wang H; Zhang X; Huo W; Qi R; Gao Y; Zhang G; Song B; Chen H; Gao X
    J Invest Dermatol; 2017 Apr; 137(4):810-818. PubMed ID: 27890786
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The DNA cytosine deaminase APOBEC3B promotes tamoxifen resistance in ER-positive breast cancer.
    Law EK; Sieuwerts AM; LaPara K; Leonard B; Starrett GJ; Molan AM; Temiz NA; Vogel RI; Meijer-van Gelder ME; Sweep FC; Span PN; Foekens JA; Martens JW; Yee D; Harris RS
    Sci Adv; 2016 Oct; 2(10):e1601737. PubMed ID: 27730215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.